|Bid||0.1400 x N/A|
|Ask||0.1450 x N/A|
|Day's Range||0.1350 - 0.1450|
|52 Week Range||0.0500 - 2.2300|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 19, 2020 - Aug 26, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.15|
VANCOUVER , May 26, 2020 /CNW/ - Zenabis Global Inc. ("Zenabis" or the "Company") announces that, after careful consideration and in accordance with applicable corporate and securities laws and stock exchange rules, it has decided to hold its annual meeting of shareholders at a date in the second half of 2020. The Company is considering an appropriate time and format for its annual meeting of shareholders and will provide further information on its annual meeting of shareholders as soon as it is available. The Company is also relying on the exemption provided in BC Instrument 51-516 – Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials (and similar exemptions provided by the other Canadian securities regulators) to postpone the filing of its executive compensation disclosure required under Section 9.3.1(2.2) of National Instrument 51-102 – Continuous Disclosure Obligations until such time as it is filed and delivered to shareholders as part of the Company's information circular relating to its 2020 annual meeting of shareholders.
VANCOUVER , May 20, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce that it has successfully received EU-GMP approval for its Atholville facility and expects to commence commercial export to the European Union in the third quarter of 2020. In addition, the Company is announcing Health Canada approval of additional growing and processing areas at Zenabis Langley.
VANCOUVER , April 30, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today provided a corporate update on its recent activities and the impact of COVID-19 on the market and operations. With respect to COVID-19, we are very pleased that to date there have been no COVID-19 cases in any of the Company's locations and that Company operations have thus far been unaffected.
VANCOUVER , Feb. 19, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced details of its cannabis derivative product ("Cannabis 2.0") strategy and execution, including entering into an agreement with a Canadian beverage manufacturer to produce a range of cannabis-infused beverages. In December 2019 , Zenabis signed a definitive agreement (the "Agreement") with HYTN Beverages Inc. ("HYTN") to produce a range of cannabis-infused beverages at Zenabis Stellarton. The initial launch of cannabis-infused sparkling water beverages under the HYTN brand are listed with all Zenabis' Provincial counterparties, with strong indicative demand.
VANCOUVER , Jan. 16, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce that the holders (the "Noteholders") of the subordinated secured convertible notes of the Company (the "Convertible Notes") have agreed to convert, at a conversion price of $0.155 per common share of the Company (each, a "Common Share"), an aggregate $6,040,176 of the principal amount of the Convertible Notes (the "Immediate Conversion"). An aggregate of 38,968,874 Common Shares will be issued to the Noteholders pursuant to the Immediate Conversion.
Zenabis Global (TSX: ZENA) (OTCQB:ZBISF) has appointed Eric Rasmussen as chief financial officer. Rasmussen replaces Mike Smyth, who is retiring. Rasmussen has vast senior management experience in publicly-listed companies, both in North America and Europe, according to a company statement. Rasmussen has experience in corporate and operations finance, internal audit, M&A, and strategic investment. More recently, he […]The post Zenabis Global Appoints New CFO appeared first on Market Exclusive.
VANCOUVER , Jan. 2, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced the appointment of Eric Rasmussen as Chief Financial Officer ("CFO"), replacing Mike Smyth , who is retiring. Mr. Rasmussen joins Zenabis with extensive senior management experience in publicly-listed companies, both in North America and Europe . More recently, Mr. Rasmussen has been a strategic consultant for Canadian large- and mid-size clients, advising on corporate strategic and financial planning, post-merger integration and business process optimization.
VANCOUVER , Dec. 16, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce the receipt of the license amendment for Zenabis Langley Part 2A, representing an additional 39,400 kg of licensed annual cultivation capacity. Zenabis has reached substantial completion on Zenabis Langley Part 2B (14,800 kg of annual cultivation capacity) and intends to submit a license amendment for this phase before the end of 2019.
VANCOUVER , Dec. 11, 2019 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announced today the appointment of Kevin Coft as interim Chief Executive Officer ("CEO"), effective immediately. Mr. Coft will replace Andrew Grieve as CEO, whose contract was set to expire shortly. While Mr. Grieve will be returning to his investment business, he has agreed to continue to provide Zenabis with his knowledge, expertise and guidance as a continuing member of Zenabis' board.
VANCOUVER , Dec. 9, 2019 /CNW/ - Zenabis Global Inc (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce that, further to its press release dated November 28, 2019 with respect to the completion of the Company's rights offering (the "Rights Offering") on November 27, 2019 (the "Closing Date"), the Company has issued 139,086,624 common shares of the Company ("Common Shares") at a price of $0.15 per Common Share for gross proceeds of $20,862,993.60 . As of the Closing Date and after taking into account the Rights Offering, the Company has a total of 347,716,561 Common Shares issued and outstanding.
VANCOUVER , Nov. 28, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce that it has closed its previously announced rights offering (the "Rights Offering"), which expired at 5:00 p.m. (EST) on November 27, 2019 . The Rights Offering was over-subscribed and will result in the issuance of the maximum of 139,086,624 common shares of the Company ("Common Shares") at a price of $0.15 per Common Share for gross proceeds of approximately $20.8 million . Zenabis is working with its transfer agent to calculate the amounts exercised under the basic subscription privilege and the additional subscription privilege in connection with the Rights Offering and will provide further details, including information required by National Instrument 45-106 – Prospectus Exemptions, once available.
VANCOUVER , Nov. 21, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced the appointment of Vincent Quan as the newest member of its Board of Directors, effective November 21, 2019 . Working previously for Farm Credit Canada, Canada's largest agriculture lender, he oversaw a team of lending professionals across British Columbia managing a portfolio in excess of $1 billion . In conjunction with joining the Board of Directors of Zenabis, Mr. Quan has committed to exercise 258,000 rights under the current rights offering.
VANCOUVER , Oct. 28, 2019 /CNW/ - Zenabis Global Inc. (ZENA.TO) ("Zenabis" or the "Company") announces that it will hold an investor conference call in listen-only mode on Tuesday October 29, 2019 at 1:30 p.m. (PDT) to discuss the recently announced offering of rights to holders of Zenabis common shares. During the call, Zenabis' Chief Executive Officer ( Andrew Grieve ), Chief Financial Officer ( Mike Smyth ), Chief Growing Officer ( Leo Benne ) and Chief Revenue Officer ( David Lluncor ) will discuss the recently announced offering of rights to holders of Zenabis common shares. Zenabis is further buttressing its cash position through a $20.8 million Rights Offering to existing shareholders.
Flower One Holdings (CSE: FONE) (OTCQX: FLOOF) has announced that its brand partner has become the top-performing cannabis flower brand in Nevada. According to Headset, a cannabis industry analytics services provider, Old Pal is now the top-performing cannabis flower brand in Nevada. Flower One is licensed to produce and distribute the entire Old Pal product line. MYM […]The post Cannabis Stock News Weekend Roundup October 27 appeared first on Market Exclusive.
VANCOUVER , Oct. 24, 2019 /CNW/ - Zenabis Global Inc. (ZENA.TO) ("Zenabis" or the "Company") announces that it will be offering rights (the "Rights Offering") to holders of its common shares ("Common Shares") of record at the close of business on October 31, 2019 (the "Record Date"). The Rights Offering is intended to raise up to $20.8 million , assuming full uptake. Insiders of Zenabis have committed to acquire 30% of the Common Shares available under the Rights Offering for a total of $6.2 million , representing strong participation.
VANCOUVER , Oct. 22, 2019 /CNW/ - Zenabis Global Inc. (ZENA.TO) ("Zenabis" or the "Company") today announced that it has entered into an agreement (the "Cultivation Agreement") with Tantalus Labs Ltd. ("Tantalus Labs"), pursuant to which Zenabis will grow and harvest cannabis plants from clones provided by Tantalus Labs. The plants will be grown and harvested at Zenabis Langley. Tantalus Labs will be responsible for all drying, trimming and packaging at its own licensed facilities.
VANCOUVER , Sept. 30, 2019 /CNW/ - Zenabis Global Inc. (ZENA.TO) ("Zenabis" or the "Company") today announced that it has entered into a definitive agreement (the "Agreement") with PAX Labs, Inc. ("PAX"), under which Zenabis will supply cannabis extracts for PAX Era Pods designed for use with the PAX Era vaporizer device. This Agreement will make Zenabis the fifth and only additional Licensed Producer ("LP") to launch PAX Era Pods, later this year, when and as permitted under applicable laws. Under the terms of the Agreement, Zenabis will supply cannabis extracts in the form of PAX Era Pods nationwide through its supply arrangements with the nine provinces and one territory, pending anticipated changes to the Cannabis Act to permit the sale of cannabis extracts for vaporization.
VANCOUVER , Sept. 23, 2019 /CNW/ - Zenabis Global Inc. (ZENA.TO) ("Zenabis" or the "Company") is pleased to announce the licensing of Phase 2C – Part 2 at Zenabis Atholville for an additional 3,000 kg of licensed annual cultivation capacity. This amendment increases licensed operating space from the existing 295,200 square feet at Zenabis Atholville to 380,000 square feet. Andrew Grieve , Chief Executive Officer of Zenabis, stated, "The receipt of the Phase 2C – Part 2 license amendment is the final key license amendment for Zenabis Atholville.